SCHEDULE 13D

Company

Lineage Cell Therapeutics, Inc.

Filed

February 3, 1997

Accession Number

0001011300-97-000007

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →